Want to see HK:2348 full AI Analyst Report?
Dawnrays Pharmaceutical Holdings Ltd. (2348) Revenue
Dawnrays Pharmaceutical Holdings Ltd. Revenue
Dawnrays Pharmaceutical Holdings Ltd. had a revenue of 538.31M in the quarter ending Jun 30, 2026, with -10.35%. This bring the company's revenue in the last twelve months to 1.14B, Decreased 7.48%. In the fiscal year ending Dec 31, 2025, Dawnrays Pharmaceutical Holdings Ltd. had annual revenue of 1.23B with 16.09% growth.
- Revenue (ttm)
- 1.14B
- Revenue Growth
- 6.55%
- P/S Ratio
- 1.13
- Revenue/Employee
- HKD 1,146,059
- Employees
- 1,074
- Market Cap
- HKD 1.39B
Revenue Chart
Dawnrays Pharmaceutical Holdings Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.23B | 170.56M | 16.09% |
| Dec 31, 2024 | 1.06B | -90.84M | -7.89% |
| Dec 31, 2023 | 1.15B | -126.54M | -9.90% |
| Dec 31, 2022 | 1.28B | 112.53M | 9.66% |
| Dec 31, 2021 | 1.17B | 140.88M | 13.75% |
| Dec 31, 2020 | 1.02B | 74.26M | 7.82% |
| Dec 31, 2019 | 950.01M | 1.07M | 0.11% |
| Dec 31, 2018 | 948.94M | 66.45M | 7.53% |
| Dec 31, 2017 | 882.48M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.